---
title: "Bionano Genomics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 6.687 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286309413.md"
datetime: "2026-05-13T20:06:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286309413.md)
  - [en](https://longbridge.com/en/news/286309413.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286309413.md)
---

# Bionano Genomics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 6.687 M

Revenue: As of FY2026 Q1, the actual value is USD 6.687 M, beating the estimate of USD 6.568 M.

EBIT: As of FY2026 Q1, the actual value is USD -8.12 M.

The provided reference is a Form 8-K filing by Bionano Genomics, Inc. which states that the company issued a press release on May 13, 2026, reporting its financial results for the first quarter ended March 31, 2026. However, the actual financial and operational metrics, cash flow data, or any outlook/guidance from this press release are not included within the provided reference text for extraction.

### Related Stocks

- [BNGO.US](https://longbridge.com/en/quote/BNGO.US.md)

## Related News & Research

- [Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt](https://longbridge.com/en/news/286311999.md)
- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [Advance Auto Parts Reports First Quarter 2026 Results; Reaffirms Full Year 2026 Guidance | AAP Stock News](https://longbridge.com/en/news/287202242.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)